01.03.2013 Views

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

UNDERSTANDING CLINICAL TRIAL DESIGN: A TUTORIAL FOR RESEARCH ADVOCATES<br />

The calculation of test-statistics is beyond the scope of this tutorial. However,<br />

three factors always influence their values, and hence how likely they are to deviate<br />

from test statistics that would have been computed had the null hypothesis been<br />

true. These are:<br />

1) Sample Size: The larger the sample, the more likely the observed outcomes<br />

reflect their overall populations. The limiting case is when the entire population<br />

is part of the clinical trial. Thus, other factors being equal, the larger the sample<br />

size, the more likely the null hypothesis will be rejected.<br />

2) Variability: The less variability among patients within each group, the more<br />

likely they reflect the overall populations. In trials with low variability, trial<br />

outcome differences between experimental and control arms are likely to be real<br />

(i.e., not due to chance). Thus, other factors being equal, the null hypothesis is<br />

more likely to be rejected in trials with low variability.<br />

3) Outcome Difference: The larger the difference in outcomes between the experimental<br />

and control arms, the more likely there is a true difference, even if it is<br />

actually smaller or larger than observed in the trial. Thus, other factors being<br />

equal, the larger differences between experimental and control arms, the more<br />

likely the null hypothesis will be rejected.<br />

How unlikely would the trial results need to be to reject the null hypothesis? This<br />

rests on researchers’ tolerance for errors. The more tolerant of errors, for example,<br />

in more exploratory work, the more likely the null hypothesis will be rejected.<br />

However, it is never actually known whether or not the null hypothesis is true.<br />

Rather, researchers establish criteria to maintain specific error rates across all trials.<br />

This is what they do when they set α or type I error rates at .5%, and β or type II<br />

error rates at 20%. Figure 9 and the following text explain these potential errors<br />

in more detail. This material is a rather technical and some readers may choose<br />

to skip to the judicial example at the end of this section.<br />

The columns of Figure 9 provide the two possible true states of affairs: either the<br />

null hypothesis (H 0 ) is true or false. The rows give the two possible decisions;<br />

either fail to reject or reject the null hypothesis. The cells show the conclusions<br />

that are drawn—either the experimental and control groups are equivalent or not—<br />

and whether the decision was correct (indicated by ☺), or an error (indicated by<br />

).<br />

Figure 9. Errors in Hypothesis Testing<br />

Truth/Decision H 0 is True H 0 is False<br />

Fail to Reject H 0<br />

Reject H 0<br />

α or type I error<br />

☺<br />

Ex = Control<br />

<br />

Ex = Control<br />

<br />

Ex = Control<br />

☺ ☺<br />

Ex = Control<br />

19<br />

β or type II error

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!